GDIR2_HUMAN - dbPTM
GDIR2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GDIR2_HUMAN
UniProt AC P52566
Protein Name Rho GDP-dissociation inhibitor 2
Gene Name ARHGDIB
Organism Homo sapiens (Human).
Sequence Length 201
Subcellular Localization Cytoplasm, cytosol .
Protein Description Regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. [PubMed: 8356058]
Protein Sequence MTEKAPEPHVEEDDDDELDSKLNYKPPPQKSLKELQEMDKDDESLIKYKKTLLGDGPVVTDPKAPNVVVTRLTLVCESAPGPITMDLTGDLEALKKETIVLKEGSEYRVKIHFKVNRDIVSGLKYVQHTYRTGVKVDKATFMVGSYGPRPEEYEFLTPVEEAPKGMLARGTYHNKSFFTDDDKQDHLSWEWNLSIKKEWTE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MTEKAPEPH
------CCCCCCCCC
46.31-
2Phosphorylation------MTEKAPEPH
------CCCCCCCCC
46.3126074081
4Acetylation----MTEKAPEPHVE
----CCCCCCCCCCC
61.1425953088
4Ubiquitination----MTEKAPEPHVE
----CCCCCCCCCCC
61.14-
20PhosphorylationDDDDELDSKLNYKPP
CCCCCCHHHCCCCCC
52.2228787133
21AcetylationDDDELDSKLNYKPPP
CCCCCHHHCCCCCCC
40.1819608861
21UbiquitinationDDDELDSKLNYKPPP
CCCCCHHHCCCCCCC
40.1819608861
24NitrationELDSKLNYKPPPQKS
CCHHHCCCCCCCCHH
35.00-
24PhosphorylationELDSKLNYKPPPQKS
CCHHHCCCCCCCCHH
35.0019321744
25AcetylationLDSKLNYKPPPQKSL
CHHHCCCCCCCCHHH
50.3919608861
25UbiquitinationLDSKLNYKPPPQKSL
CHHHCCCCCCCCHHH
50.3919608861
30AcetylationNYKPPPQKSLKELQE
CCCCCCCHHHHHHHH
64.6323749302
30UbiquitinationNYKPPPQKSLKELQE
CCCCCCCHHHHHHHH
64.6319608861
31PhosphorylationYKPPPQKSLKELQEM
CCCCCCHHHHHHHHC
39.1529978859
33UbiquitinationPPPQKSLKELQEMDK
CCCCHHHHHHHHCCC
64.57-
33AcetylationPPPQKSLKELQEMDK
CCCCHHHHHHHHCCC
64.5723749302
38SulfoxidationSLKELQEMDKDDESL
HHHHHHHCCCCCHHH
5.1128465586
40UbiquitinationKELQEMDKDDESLIK
HHHHHCCCCCHHHHH
66.8119608861
40AcetylationKELQEMDKDDESLIK
HHHHHCCCCCHHHHH
66.8119608861
44PhosphorylationEMDKDDESLIKYKKT
HCCCCCHHHHHHHHH
42.2528348404
47UbiquitinationKDDESLIKYKKTLLG
CCCHHHHHHHHHHHC
57.2019608861
47AcetylationKDDESLIKYKKTLLG
CCCHHHHHHHHHHHC
57.2019608861
48PhosphorylationDDESLIKYKKTLLGD
CCHHHHHHHHHHHCC
15.6629978859
49UbiquitinationDESLIKYKKTLLGDG
CHHHHHHHHHHHCCC
33.99-
50UbiquitinationESLIKYKKTLLGDGP
HHHHHHHHHHHCCCC
41.1221890473
50UbiquitinationESLIKYKKTLLGDGP
HHHHHHHHHHHCCCC
41.1221890473
51PhosphorylationSLIKYKKTLLGDGPV
HHHHHHHHHHCCCCC
24.0623911959
60PhosphorylationLGDGPVVTDPKAPNV
HCCCCCCCCCCCCCE
46.9823911959
63AcetylationGPVVTDPKAPNVVVT
CCCCCCCCCCCEEEE
78.3323749302
63UbiquitinationGPVVTDPKAPNVVVT
CCCCCCCCCCCEEEE
78.33-
70O-linked_GlycosylationKAPNVVVTRLTLVCE
CCCCEEEEEEEEEEE
14.3530379171
73PhosphorylationNVVVTRLTLVCESAP
CEEEEEEEEEEECCC
17.5428122231
73O-linked_GlycosylationNVVVTRLTLVCESAP
CEEEEEEEEEEECCC
17.5430379171
76S-nitrosylationVTRLTLVCESAPGPI
EEEEEEEEECCCCCE
3.7325040305
78PhosphorylationRLTLVCESAPGPITM
EEEEEEECCCCCEEE
34.3428122231
95UbiquitinationTGDLEALKKETIVLK
CCCHHHHHHCEEEEE
56.46-
95AcetylationTGDLEALKKETIVLK
CCCHHHHHHCEEEEE
56.4626822725
96UbiquitinationGDLEALKKETIVLKE
CCHHHHHHCEEEEEC
62.02-
102UbiquitinationKKETIVLKEGSEYRV
HHCEEEEECCCEEEE
49.4919608861
102AcetylationKKETIVLKEGSEYRV
HHCEEEEECCCEEEE
49.4919608861
110UbiquitinationEGSEYRVKIHFKVNR
CCCEEEEEEEEEECC
22.82-
114UbiquitinationYRVKIHFKVNRDIVS
EEEEEEEEECCHHHH
25.16-
114AcetylationYRVKIHFKVNRDIVS
EEEEEEEEECCHHHH
25.1625953088
124UbiquitinationRDIVSGLKYVQHTYR
CHHHHHCEEEEEECC
47.0721890473
124UbiquitinationRDIVSGLKYVQHTYR
CHHHHHCEEEEEECC
47.0721906983
124AcetylationRDIVSGLKYVQHTYR
CHHHHHCEEEEEECC
47.0719608861
125PhosphorylationDIVSGLKYVQHTYRT
HHHHHCEEEEEECCC
15.4723882029
129PhosphorylationGLKYVQHTYRTGVKV
HCEEEEEECCCCCEE
9.5228176486
130PhosphorylationLKYVQHTYRTGVKVD
CEEEEEECCCCCEEC
12.2128176486
132PhosphorylationYVQHTYRTGVKVDKA
EEEEECCCCCEECEE
35.5927080861
135AcetylationHTYRTGVKVDKATFM
EECCCCCEECEEEEE
46.1723749302
135UbiquitinationHTYRTGVKVDKATFM
EECCCCCEECEEEEE
46.17-
138AcetylationRTGVKVDKATFMVGS
CCCCEECEEEEEEEC
52.9223749302
138UbiquitinationRTGVKVDKATFMVGS
CCCCEECEEEEEEEC
52.92-
140PhosphorylationGVKVDKATFMVGSYG
CCEECEEEEEEECCC
20.2928464451
145PhosphorylationKATFMVGSYGPRPEE
EEEEEEECCCCCHHH
18.5922617229
146PhosphorylationATFMVGSYGPRPEEY
EEEEEECCCCCHHHC
25.8122115753
153PhosphorylationYGPRPEEYEFLTPVE
CCCCHHHCEEEEEHH
15.4319321744
157PhosphorylationPEEYEFLTPVEEAPK
HHHCEEEEEHHHCCC
30.5230108239
164UbiquitinationTPVEEAPKGMLARGT
EEHHHCCCCCCCCCC
65.0921890473
175UbiquitinationARGTYHNKSFFTDDD
CCCCCCCCCCCCCCC
35.0119608861
175AcetylationARGTYHNKSFFTDDD
CCCCCCCCCCCCCCC
35.0119608861
179PhosphorylationYHNKSFFTDDDKQDH
CCCCCCCCCCCCCCC
36.19-
194PhosphorylationLSWEWNLSIKKEWTE
CEEEEEEEEEECCCC
29.2027251275
196AcetylationWEWNLSIKKEWTE--
EEEEEEEEECCCC--
41.0625953088
197AcetylationEWNLSIKKEWTE---
EEEEEEEECCCC---
57.7311921139

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
24YPhosphorylationKinaseSYKP43405
PSP
24YPhosphorylationKinaseSRCP12931
PSP
31SPhosphorylationKinasePRKCAP17252
GPS
130YPhosphorylationKinaseABLP00519
PSP
153YPhosphorylationKinaseSRCP12931
PSP
-KUbiquitinationE3 ubiquitin ligaseRNF128Q8TEB7
PMID:17114425

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GDIR2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GDIR2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
VAV_HUMANVAV1physical
10664460
A4_HUMANAPPphysical
21832049
RHOC_HUMANRHOCphysical
26344197
SUMO4_HUMANSUMO4physical
26344197
WSB1_HUMANWSB1physical
26424695
FBXL5_HUMANFBXL5physical
27383304

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GDIR2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-21; LYS-25; LYS-40; LYS-47;LYS-102; LYS-124 AND LYS-175, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-145, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24, AND MASSSPECTROMETRY.

TOP